IZM
ICZOOM Group Inc.
Technology Distributors
Market Cap$1M
5Y Perf.-77.8%
Compare Stocks
4 / 10Try these comparisons:
Stock Comparison
IZM vs ACMR vs ICHR vs LIQT
Revenue, margins, valuation, and 5-year total return — side by side.
ACMR
ACM Research, Inc.
Semiconductors
Market Cap$3.92B
5Y Perf.+406.0%
ICHR
Ichor Holdings, Ltd.
Semiconductors
Market Cap$2.47B
5Y Perf.+117.6%
LIQT
LiqTech International, Inc.
Industrial - Pollution & Treatment Controls
Market Cap$22M
5Y Perf.-38.6%
IZM vs ACMR vs ICHR vs LIQT — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | IZM | ACMR | ICHR | LIQT |
|---|---|---|---|---|
| Industry | Technology Distributors | Semiconductors | Semiconductors | Industrial - Pollution & Treatment Controls |
| Market Cap | $1M | $3.92B | $2.47B | $22M |
| Revenue (TTM) | $362M | $901M | $959M | $17M |
| Net Income (TTM) | $-667K | $94M | $-51M | $-9M |
| Gross Margin | 2.8% | 44.4% | 11.3% | 4.9% |
| Operating Margin | -0.2% | 12.1% | -3.8% | -50.0% |
| Forward P/E | — | 29.7x | 62.2x | — |
| Total Debt | $12M | $303M | $186M | $12M |
| Cash & Equiv. | $2M | $766M | $98M | — |
IZM vs ACMR vs ICHR vs LIQT — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
IZM
ACMR
ICHR
LIQT
| Stock | Mar 23 | May 26 | Return |
|---|---|---|---|
| ICZOOM Group Inc. (IZM) | 100 | 22.2 | -77.8% |
| ACM Research, Inc. (ACMR) | 100 | 506.0 | +406.0% |
| Ichor Holdings, Ltd. (ICHR) | 100 | 217.6 | +117.6% |
| LiqTech Internation… (LIQT) | 100 | 61.4 | -38.6% |
Price return only. Dividends and distributions are not included.
Quick Verdict: IZM vs ACMR vs ICHR vs LIQT
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: ACMR leads in 5 of 7 categories, making it the strongest pick for growth and revenue expansion and valuation and capital efficiency. Ichor Holdings, Ltd. is the stronger pick specifically for recent price momentum and sentiment. LIQT also leads in specific categories worth noting. This set spans 2 sectors — these stocks serve different portfolio roles, not just different price points.
IZM
ICZOOM Group Inc.
The Lower-Volatility Pick
IZM lags the leaders in this set but could rank higher in a more targeted comparison.
Best for: technology exposure
ACMR
ACM Research, Inc.
The Income Pick
ACMR carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 3 yrs, beta 3.24, yield 0.2%
- Rev growth 15.2%, EPS growth -10.5%, 3Y rev CAGR 32.3%
- 30.7% 10Y total return vs ICHR's 6.3%
- Lower volatility, beta 3.24, Low D/E 15.7%, current ratio 3.27x
Best for: income & stability and growth exposure
ICHR
Ichor Holdings, Ltd.
The Momentum Pick
ICHR is the #2 pick in this set and the best alternative if momentum is your priority.
- +329.1% vs IZM's -81.6%
Best for: momentum
LIQT
LiqTech International, Inc.
The Defensive Choice
LIQT is the clearest fit if your priority is stability.
- Beta 0.52 vs ICHR's 3.93
Best for: stability
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ACMR | 15.2% revenue growth vs IZM's -17.0% |
| Value | ACMR | Better valuation composite |
| Quality / Margins | ACMR | 10.4% margin vs LIQT's -53.3% |
| Stability / Safety | LIQT | Beta 0.52 vs ICHR's 3.93 |
| Dividends | ACMR | 0.2% yield; 3-year raise streak; the other 3 pay no meaningful dividend |
| Momentum (1Y) | ICHR | +329.1% vs IZM's -81.6% |
| Efficiency (ROA) | ACMR | 3.9% ROA vs LIQT's -29.5%, ROIC 7.0% vs -31.1% |
IZM vs ACMR vs ICHR vs LIQT — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
FY 2024
FY 2025
Segment breakdown not available.
FY 2024
IZM vs ACMR vs ICHR vs LIQT — Financial Metrics
Side-by-side numbers across 4 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLACMRLAGGINGLIQT
Who Leads Where
ACMR leads in 4 of 6 categories
IZM leads 1 • ICHR leads 0 • LIQT leads 0 • 1 tied
Explore the data ↓LIQTLiqTech International…
0leads
ICHRIchor Holdings, Ltd.
0leads
IZMICZOOM Group Inc.
1leads
ACMRACM Research, Inc.
4leads
6 Total Categories
CATEGORYLEADERvs IZMvs ICHRMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
ACMR3/6
Valuation MetricsMultiples, price ratios, and targets
IZM2/4
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
ACMR7/9
Total Returns1Y, 3Y, 5Y total returns with dividends
ACMR4/6
Risk & VolatilityBeta, volatility, and downside exposure
Tied
—
Analyst OutlookRatings, price targets, and dividends
ACMR1/1
Income & Cash Flow (Last 12 Months)
ACMR leads this category, winning 3 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ICHR is the larger business by revenue, generating $959M annually — 57.1x LIQT's $17M. ACMR is the more profitable business, keeping 10.4% of every revenue dollar as net income compared to LIQT's -53.3%. On growth, LIQT holds the edge at +53.6% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | IZMICZOOM Group Inc. | ACMRACM Research, Inc. | ICHRIchor Holdings, L… | LIQTLiqTech Internati… |
|---|---|---|---|---|
| RevenueTrailing 12 months | $362M | $901M | $959M | $17M |
| EBITDAEarnings before interest/tax | $184,236 | $126M | -$11M | -$6M |
| Net IncomeAfter-tax profit | -$666,903 | $94M | -$51M | -$9M |
| Free Cash FlowCash after capex | $2M | -$69M | -$17M | -$7M |
| Gross MarginGross profit ÷ Revenue | +2.8% | +44.4% | +11.3% | +4.9% |
| Operating MarginEBIT ÷ Revenue | -0.2% | +12.1% | -3.8% | -50.0% |
| Net MarginNet income ÷ Revenue | -0.2% | +10.4% | -5.3% | -53.3% |
| FCF MarginFCF ÷ Revenue | +0.4% | -7.6% | -1.7% | -39.3% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.0% | +9.4% | +4.7% | +53.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.0% | -76.1% | +46.2% | +69.4% |
ACMR leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
IZM leads this category, winning 2 of 4 comparable metrics.
Valuation Metrics
| Metric | IZMICZOOM Group Inc. | ACMRACM Research, Inc. | ICHRIchor Holdings, L… | LIQTLiqTech Internati… |
|---|---|---|---|---|
| Market CapShares × price | $1M | $3.9B | $2.5B | $22M |
| Enterprise ValueMkt cap + debt − cash | $11M | $3.5B | $2.6B | $34M |
| Trailing P/EPrice ÷ TTM EPS | -1.74x | 43.21x | -46.25x | -2.59x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 29.68x | 62.25x | — |
| PEG RatioP/E ÷ EPS growth rate | — | 1.22x | — | — |
| EV / EBITDAEnterprise value multiple | — | 27.49x | — | — |
| Price / SalesMarket cap ÷ Revenue | 0.01x | 4.35x | 2.61x | 1.35x |
| Price / BookPrice ÷ Book value/share | 0.26x | 2.06x | 3.67x | 2.14x |
| Price / FCFMarket cap ÷ FCF | 0.76x | — | — | — |
IZM leads this category, winning 2 of 4 comparable metrics.
Profitability & Efficiency
ACMR leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ACMR delivers a 6.1% return on equity — every $100 of shareholder capital generates $6 in annual profit, vs $-70 for LIQT. ACMR carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to LIQT's 1.17x. On the Piotroski fundamental quality scale (0–9), IZM scores 5/9 vs LIQT's 2/9, reflecting solid financial health.
| Metric | IZMICZOOM Group Inc. | ACMRACM Research, Inc. | ICHRIchor Holdings, L… | LIQTLiqTech Internati… |
|---|---|---|---|---|
| ROE (TTM)Return on equity | -4.3% | +6.1% | -7.5% | -70.0% |
| ROA (TTM)Return on assets | -1.5% | +3.9% | -5.2% | -29.5% |
| ROICReturn on invested capital | -4.1% | +7.0% | -3.9% | -31.1% |
| ROCEReturn on capital employed | -8.6% | +6.6% | -4.7% | — |
| Piotroski ScoreFundamental quality 0–9 | 5 | 2 | 3 | 2 |
| Debt / EquityFinancial leverage | 0.79x | 0.16x | 0.28x | 1.17x |
| Net DebtTotal debt minus cash | $10M | -$463M | $87M | $12M |
| Cash & Equiv.Liquid assets | $2M | $766M | $98M | — |
| Total DebtShort + long-term debt | $12M | $303M | $186M | $12M |
| Interest CoverageEBIT ÷ Interest expense | -0.31x | 20.44x | -5.97x | -13.46x |
ACMR leads this category, winning 7 of 9 comparable metrics.
Total Returns (Dividends Reinvested)
ACMR leads this category, winning 4 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ACMR five years ago would be worth $23,344 today (with dividends reinvested), compared to $391 for LIQT. Over the past 12 months, ICHR leads with a +329.1% total return vs IZM's -81.6%. The 3-year compound annual growth rate (CAGR) favors ACMR at 80.5% vs IZM's -47.9% — a key indicator of consistent wealth creation.
| Metric | IZMICZOOM Group Inc. | ACMRACM Research, Inc. | ICHRIchor Holdings, L… | LIQTLiqTech Internati… |
|---|---|---|---|---|
| YTD ReturnYear-to-date | -85.1% | +31.9% | +249.0% | +54.9% |
| 1-Year ReturnPast 12 months | -81.6% | +195.6% | +329.1% | +64.8% |
| 3-Year ReturnCumulative with dividends | -85.9% | +487.9% | +151.1% | -31.3% |
| 5-Year ReturnCumulative with dividends | -88.4% | +133.4% | +28.9% | -96.1% |
| 10-Year ReturnCumulative with dividends | -88.4% | +3065.8% | +629.1% | -90.9% |
| CAGR (3Y)Annualised 3-year return | -47.9% | +80.5% | +35.9% | -11.8% |
ACMR leads this category, winning 4 of 6 comparable metrics.
Risk & Volatility
Evenly matched — IZM and ICHR each lead in 1 of 2 comparable metrics.
Risk & Volatility
IZM is the less volatile stock with a -0.74 beta — it tends to amplify market swings less than ICHR's 3.93 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. ICHR currently trades 97.7% from its 52-week high vs IZM's 14.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | IZMICZOOM Group Inc. | ACMRACM Research, Inc. | ICHRIchor Holdings, L… | LIQTLiqTech Internati… |
|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | -0.74x | 3.24x | 3.93x | 0.52x |
| 52-Week HighHighest price in past year | $2.74 | $71.65 | $72.87 | $3.35 |
| 52-Week LowLowest price in past year | $0.34 | $19.26 | $13.12 | $1.30 |
| % of 52W HighCurrent price vs 52-week peak | +14.0% | +82.6% | +97.7% | +68.9% |
| RSI (14)Momentum oscillator 0–100 | 41.4 | 60.7 | 66.9 | 57.0 |
| Avg Volume (50D)Average daily shares traded | 2.0M | 1.2M | 795K | 50K |
Evenly matched — IZM and ICHR each lead in 1 of 2 comparable metrics.
Analyst Outlook
ACMR leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Analyst consensus: ACMR as "Buy", ICHR as "Buy". Consensus price targets imply -30.1% upside for ICHR (target: $50) vs -32.4% for ACMR (target: $40). ACMR is the only dividend payer here at 0.19% yield — a key consideration for income-focused portfolios.
| Metric | IZMICZOOM Group Inc. | ACMRACM Research, Inc. | ICHRIchor Holdings, L… | LIQTLiqTech Internati… |
|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | — |
| Price TargetConsensus 12-month target | — | $40.00 | $49.80 | — |
| # AnalystsCovering analysts | — | 10 | 14 | — |
| Dividend YieldAnnual dividend ÷ price | — | +0.2% | — | — |
| Dividend StreakConsecutive years of raises | — | 3 | 1 | — |
| Dividend / ShareAnnual DPS | — | $0.11 | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +0.2% | 0.0% | 0.0% |
ACMR leads this category, winning 1 of 1 comparable metric.
Key Takeaway
ACMR leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). IZM leads in 1 (Valuation Metrics). 1 tied.
Best OverallACM Research, Inc. (ACMR)Leads 4 of 6 categories
Loading custom metrics...
IZM vs ACMR vs ICHR vs LIQT: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is IZM or ACMR or ICHR or LIQT a better buy right now?
For growth investors, ACM Research, Inc.
(ACMR) is the stronger pick with 15. 2% revenue growth year-over-year, versus -17. 0% for ICZOOM Group Inc. (IZM). ACM Research, Inc. (ACMR) offers the better valuation at 43. 2x trailing P/E (29. 7x forward), making it the more compelling value choice. Analysts rate ACM Research, Inc. (ACMR) a "Buy" — based on 10 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — IZM or ACMR or ICHR or LIQT?
On forward P/E, ACM Research, Inc.
is actually cheaper at 29. 7x.
03Which is the better long-term investment — IZM or ACMR or ICHR or LIQT?
Over the past 5 years, ACM Research, Inc.
(ACMR) delivered a total return of +133. 4%, compared to -96. 1% for LiqTech International, Inc. (LIQT). Over 10 years, the gap is even starker: ACMR returned +30. 7% versus LIQT's -90. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — IZM or ACMR or ICHR or LIQT?
By beta (market sensitivity over 5 years), ICZOOM Group Inc.
(IZM) is the lower-risk stock at -0. 74β versus Ichor Holdings, Ltd. 's 3. 93β — meaning ICHR is approximately -634% more volatile than IZM relative to the S&P 500. On balance sheet safety, ACM Research, Inc. (ACMR) carries a lower debt/equity ratio of 16% versus 117% for LiqTech International, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — IZM or ACMR or ICHR or LIQT?
By revenue growth (latest reported year), ACM Research, Inc.
(ACMR) is pulling ahead at 15. 2% versus -17. 0% for ICZOOM Group Inc. (IZM). On earnings-per-share growth, the picture is similar: LiqTech International, Inc. grew EPS 45. 7% year-over-year, compared to -229. 4% for ICZOOM Group Inc.. Over a 3-year CAGR, ACMR leads at 32. 3% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — IZM or ACMR or ICHR or LIQT?
ACM Research, Inc.
(ACMR) is the more profitable company, earning 10. 4% net margin versus -51. 7% for LiqTech International, Inc. — meaning it keeps 10. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ACMR leads at 12. 1% versus -50. 3% for LIQT. At the gross margin level — before operating expenses — ACMR leads at 44. 4%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is IZM or ACMR or ICHR or LIQT more undervalued right now?
On forward earnings alone, ACM Research, Inc.
(ACMR) trades at 29. 7x forward P/E versus 62. 2x for Ichor Holdings, Ltd. — 32. 6x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ICHR: -30. 1% to $49. 80.
08Which pays a better dividend — IZM or ACMR or ICHR or LIQT?
In this comparison, ACMR (0.
2% yield) pays a dividend. IZM, ICHR, LIQT do not pay a meaningful dividend and should not be held primarily for income.
09Is IZM or ACMR or ICHR or LIQT better for a retirement portfolio?
For long-horizon retirement investors, ICZOOM Group Inc.
(IZM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0. 74)). ACM Research, Inc. (ACMR) carries a higher beta of 3. 24 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (IZM: -88. 4%, ACMR: +30. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between IZM and ACMR and ICHR and LIQT?
These companies operate in different sectors (IZM (Technology) and ACMR (Technology) and ICHR (Technology) and LIQT (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: IZM is a small-cap quality compounder stock; ACMR is a small-cap high-growth stock; ICHR is a small-cap quality compounder stock; LIQT is a small-cap quality compounder stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
Revenue Growth>
%
(IZM: 3.0% · ACMR: 9.4%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.